NO20022446L - Etere av O-desmetyl-venlafaxine - Google Patents
Etere av O-desmetyl-venlafaxineInfo
- Publication number
- NO20022446L NO20022446L NO20022446A NO20022446A NO20022446L NO 20022446 L NO20022446 L NO 20022446L NO 20022446 A NO20022446 A NO 20022446A NO 20022446 A NO20022446 A NO 20022446A NO 20022446 L NO20022446 L NO 20022446L
- Authority
- NO
- Norway
- Prior art keywords
- desmethyl
- venlafaxine
- ethers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44826899A | 1999-11-24 | 1999-11-24 | |
PCT/US2000/031895 WO2001038293A1 (en) | 1999-11-24 | 2000-11-21 | Ethers of o-desmethyl venlafaxine |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20022446L true NO20022446L (no) | 2002-05-23 |
NO20022446D0 NO20022446D0 (no) | 2002-05-23 |
Family
ID=23779642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20022446A NO20022446D0 (no) | 1999-11-24 | 2002-05-23 | Etere av O-desmetyl-venlafaxine |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP1232141B1 (no) |
JP (1) | JP2003514889A (no) |
KR (1) | KR100843991B1 (no) |
CN (2) | CN1636559A (no) |
AR (1) | AR024498A1 (no) |
AT (1) | ATE278659T1 (no) |
AU (1) | AU767835B2 (no) |
BR (1) | BR0015795A (no) |
CA (1) | CA2391288A1 (no) |
CZ (1) | CZ20021816A3 (no) |
DE (1) | DE60014693T2 (no) |
DK (1) | DK1232141T3 (no) |
ES (1) | ES2228636T3 (no) |
HK (1) | HK1045835A1 (no) |
HU (1) | HUP0203594A2 (no) |
IL (2) | IL149531A0 (no) |
MX (1) | MXPA02005174A (no) |
NO (1) | NO20022446D0 (no) |
NZ (1) | NZ519130A (no) |
PL (1) | PL202846B1 (no) |
PT (1) | PT1232141E (no) |
SI (1) | SI1232141T1 (no) |
TW (1) | TWI268919B (no) |
WO (1) | WO2001038293A1 (no) |
ZA (1) | ZA200204986B (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6602911B2 (en) * | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
PL2621891T3 (pl) * | 2010-10-01 | 2020-11-16 | Shan Dong Luye Pharmaceutical Co., Ltd. | Polimorfy chloroworodku 4-metylobenzoesanu 4-[2 dimetyloamino-1-(1- hydroksycykloheksylo)etylo]fenylu, sposoby ich przygotowania i stosowania |
CN103319373B (zh) * | 2012-03-23 | 2017-09-19 | 浙江九洲药业股份有限公司 | 1‑[2‑氨基‑1‑(4‑苄氧基苯基)乙基]环己烷醇的制备方法及相关中间体 |
-
2000
- 2000-11-21 SI SI200030509T patent/SI1232141T1/xx unknown
- 2000-11-21 ES ES00980588T patent/ES2228636T3/es not_active Expired - Lifetime
- 2000-11-21 CZ CZ20021816A patent/CZ20021816A3/cs unknown
- 2000-11-21 PL PL355171A patent/PL202846B1/pl not_active IP Right Cessation
- 2000-11-21 CA CA002391288A patent/CA2391288A1/en not_active Abandoned
- 2000-11-21 AT AT00980588T patent/ATE278659T1/de not_active IP Right Cessation
- 2000-11-21 PT PT00980588T patent/PT1232141E/pt unknown
- 2000-11-21 BR BR0015795-3A patent/BR0015795A/pt active Pending
- 2000-11-21 DE DE60014693T patent/DE60014693T2/de not_active Expired - Fee Related
- 2000-11-21 WO PCT/US2000/031895 patent/WO2001038293A1/en active IP Right Grant
- 2000-11-21 AU AU17833/01A patent/AU767835B2/en not_active Ceased
- 2000-11-21 MX MXPA02005174A patent/MXPA02005174A/es active IP Right Grant
- 2000-11-21 NZ NZ519130A patent/NZ519130A/en unknown
- 2000-11-21 DK DK00980588T patent/DK1232141T3/da active
- 2000-11-21 CN CNA2004100882450A patent/CN1636559A/zh active Pending
- 2000-11-21 KR KR1020027006602A patent/KR100843991B1/ko not_active IP Right Cessation
- 2000-11-21 EP EP00980588A patent/EP1232141B1/en not_active Expired - Lifetime
- 2000-11-21 HU HU0203594A patent/HUP0203594A2/hu unknown
- 2000-11-21 JP JP2001539850A patent/JP2003514889A/ja not_active Withdrawn
- 2000-11-21 IL IL14953100A patent/IL149531A0/xx unknown
- 2000-11-21 CN CNB008161496A patent/CN1198793C/zh not_active Expired - Fee Related
- 2000-11-22 AR ARP000106165A patent/AR024498A1/es unknown
- 2000-11-23 TW TW089124917A patent/TWI268919B/zh not_active IP Right Cessation
-
2002
- 2002-05-08 IL IL149531A patent/IL149531A/en not_active IP Right Cessation
- 2002-05-23 NO NO20022446A patent/NO20022446D0/no not_active Application Discontinuation
- 2002-06-20 ZA ZA200204986A patent/ZA200204986B/en unknown
- 2002-10-09 HK HK02107379A patent/HK1045835A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TWI268919B (en) | 2006-12-21 |
IL149531A0 (en) | 2002-11-10 |
HK1045835A1 (en) | 2002-12-13 |
AR024498A1 (es) | 2002-10-02 |
JP2003514889A (ja) | 2003-04-22 |
CN1399626A (zh) | 2003-02-26 |
CN1636559A (zh) | 2005-07-13 |
ATE278659T1 (de) | 2004-10-15 |
AU1783301A (en) | 2001-06-04 |
EP1232141A1 (en) | 2002-08-21 |
AU767835B2 (en) | 2003-11-27 |
CN1198793C (zh) | 2005-04-27 |
KR100843991B1 (ko) | 2008-07-07 |
PL202846B1 (pl) | 2009-07-31 |
IL149531A (en) | 2008-12-29 |
KR20030058931A (ko) | 2003-07-07 |
DK1232141T3 (da) | 2004-11-29 |
ES2228636T3 (es) | 2005-04-16 |
HUP0203594A2 (en) | 2003-02-28 |
EP1232141B1 (en) | 2004-10-06 |
NZ519130A (en) | 2003-09-26 |
SI1232141T1 (en) | 2004-12-31 |
BR0015795A (pt) | 2002-07-23 |
NO20022446D0 (no) | 2002-05-23 |
ZA200204986B (en) | 2003-09-27 |
CZ20021816A3 (cs) | 2002-08-14 |
MXPA02005174A (es) | 2002-11-07 |
PT1232141E (pt) | 2004-12-31 |
WO2001038293A1 (en) | 2001-05-31 |
DE60014693D1 (en) | 2004-11-11 |
DE60014693T2 (de) | 2005-03-10 |
CA2391288A1 (en) | 2001-05-31 |
PL355171A1 (en) | 2004-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR028567A1 (es) | Nuevos derivados de fenil-propargileter | |
ID30233A (id) | Antibiotika ketolida | |
IS2325B (is) | Örgerðar samsetningar epleróns | |
AR028596A1 (es) | Nuevos derivados de fenilglicina | |
DK1237408T3 (da) | Hæld-på-formuleringer | |
EE200200150A (et) | Preparaat | |
ATE270270T1 (de) | Neuartige phenylalkyloxy-phenyl-derivate | |
NO990431D0 (no) | Golfk°llehode | |
IS6398A (is) | Lyfjablöndur | |
FI19992855A (fi) | Valaisuolosuhteiden mittaus | |
PT1246817E (pt) | Derivados de 4-fenil-1-piperazinilo, -piperidinilo e -tetra-hidropiridilo | |
PT1022396E (pt) | Combinacao de duche | |
NO20016151D0 (no) | Fremstilling av substituerte piperidin-4-oner | |
DE50015795D1 (de) | Sektionaltor | |
FI990937A0 (fi) | Tilaajahallinta | |
ID28032A (id) | TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2 | |
EE200200389A (et) | Imidasooli uued derivaadid | |
PT1178984E (pt) | Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano | |
NO20014845D0 (no) | Anvendelse av arylalkanoylpyridaziner | |
NO20022446D0 (no) | Etere av O-desmetyl-venlafaxine | |
PT1175417E (pt) | Compostos substituidos de benzolactamas | |
NO20005856D0 (no) | Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner | |
NO20021234L (no) | Anvendelse av tienopyrimidiner | |
SE9902239D0 (sv) | Kornisch bestående av flera delar | |
EE200200053A (et) | Isoretinoiini valmistamise protsess |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |